Brief: Zivo Bioscience Inc Says Co Received An Email From DAHL
01/03/2022 22:26
March 1 (Reuters) - Zivo Bioscience Inc ZIVO.O :
* ZIVO BIOSCIENCE INC - ON FEBRUARY 25, 2022, COMPANY
RECEIVED AN
EMAIL FROM DAHL
* ZIVO BIOSCIENCE INC - BOARD AND COMPANY DO NOT AGREE WITH
CERTAIN STATEMENTS CONTAINED IN DAHL'S EMAIL
* ZIVO BIOSCIENCE - REAFFIRMS THAT CO OFFERED DAHL
OPPORTUNITY TO
RESIGN FROM HIS POSITION AS CEO AND PRESIDENT OF COMPANY PRIOR
TO OFFICIAL TERMINATION
* ZIVO BIOSCIENCE INC - REAFFIRMS THAT BOARD TERMINATED DAHL
FOR
CAUSE
Further company coverage: ZIVO.O
Recent news on Zivo Bioscience
See all newsBrief: Zivo Bioscience Plans New Study With University Of Delaware To Combat Avian Influenza In Poultry
Brief: Zivo Bioscience Reports Preliminary Efficacy Of Its Proprietary Active Ingredients In Battle Against Avian Influenza
Brief: Zivo Bioscience Initiates 42-Day Validation Study With Immune-Modulating Product
Brief: Zivo Bioscience Announces Reverse Stock Split
Brief: Trial Results Confirm Efficacy Of Zivo Bioscience’S Non-Antibiotic Product Candidate For The Prevention And Treatment Of Coccidiosis In Broiler Chickens